Thromb Haemost 2007; 98(04): 783-789
DOI: 10.1160/TH07-03-0211
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

A large deletion of the PROS1 gene in a deep vein thrombosis patient with protein S deficiency

Tong Yin
1   Research Institute, National Cardiovascular Center, Osaka, Japan
,
Satoshi Takeshita
2   Department of Medicine and National Cardiovascular Center, Osaka, Japan
,
Yukiko Sato
1   Research Institute, National Cardiovascular Center, Osaka, Japan
,
Toshiyuki Sakata
3   Laboratory for Clinical Chemistry, National Cardiovascular Center, Osaka, Japan
,
Yongchol Shin
1   Research Institute, National Cardiovascular Center, Osaka, Japan
,
Shigenori Honda
1   Research Institute, National Cardiovascular Center, Osaka, Japan
,
Tomio Kawasaki
4   Department of Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan
,
Hajime Tsuji
5   Division of Blood Transfusion and Cell Therapy, Kyoto Prefectural University of Medicine, Kyoto, Japan
,
Tetsuhito Kojima
6   Department of Medical Technology, Nagoya University of School of Health Sciences, Nagoya, Japan
,
Seiji Madoiwa
7   Division on Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical School, Shimotsuke, Tochigi, Japan
,
Yoichi Sakata
7   Division on Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical School, Shimotsuke, Tochigi, Japan
,
Mitsuru Murata
8   Departments of Laboratory Medicine, Keio University, Tokyo, Japan
,
Yasuo Ikeda
9   Departments of Internal Medicine, Keio University, Tokyo, Japan
,
Toshiyuki Miyata
1   Research Institute, National Cardiovascular Center, Osaka, Japan
› Author Affiliations
Financial support: This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan, a Grant-in-Aid from the Ministry of Health, Labor, and Welfare of Japan, and the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Tong Yin, M.D., is a recipient of Takeda Foundation, from Institute of Geriatric Cardiology, General Hospital of People’s Liberation Army, Beijing, China.
Further Information

Publication History

Received 21 March 2007

Accepted after resubmission 25 July 2007

Publication Date:
01 December 2017 (online)

Summary

Inherited deficiency of protein S encoded by the PROS1 gene constitutes an important risk factor for deep vein thrombosis (DVT). Nevertheless, although more than 200 deleterious genetic variations in PROS1 have been identified, causative point mutations of PROS1 gene are not detected in approximately half of protein S-deficient families. The present study investigated whether there may exist a large deletion in PROS1 that constitutes a genetic risk factor for Japanese DVT patients. A multiplex ligation-dependent probe amplification analysis was employed to identify the deletions in PROS1 in 163 Japanese patients with DVT. A large gene deletion was identified in one patient who showed 16% protein S activity and did not carry point mutations in PROS1 by DNA sequencing and it was validated by the quantitative PCR method. The deletion spanned at least the whole PROS1 gene (107 kb) and at most from the centromere located downstream of PROS1, to before the D3S3619 marker, the first heterozygous marker in the upstream of PROS1 in chromosome 3. In conclusion, a large deletion in PROS1 was shown to partly account for DVT with protein S deficiency. Screening for large deletions in PROS1 might be warranted in PROS1 causative point mutation-negative DVT patients with protein S deficiency.

 
  • References

  • 1 Lane DA, Mannucci PM, Bauer KA. et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76: 651-662.
  • 2 Dykes AC, Walker ID, McMahon AD. et al. A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001; 113: 636-641.
  • 3 Sakata T, Okamoto A, Mannami T. et al. Prevalence of protein S deficiency in the Japanese general population: the Suita Study. JThromb Haemost 2004; 2: 1012-1013.
  • 4 Beauchamp NJ, Dykes AC, Parikh N. et al. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol 2004; 125: 647-654.
  • 5 Kimura R, Honda S, Kawasaki T. et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood 2006; 107: 1737-1738.
  • 6 Kinoshita S, Iida H, Inoue S. et al. Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem 2005; 38: 908-915.
  • 7 Miyata T, Kimura R, Kokubo Y. et al. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol 2006; 83: 217-223.
  • 8 Kimura R, Sakata T, Kokubo Y. et al. Plasma protein S activity correlates with protein S genotype but is not sensitive to identify K196E mutant carriers. J Thromb Haemost 2006; 4: 2010-2013.
  • 9 Watkins PC, Eddy R, Fukushima Y. et al. The gene for protein S maps near the centromere of human chromosome 3. Blood 1988; 71: 238-241.
  • 10 Edenbrandt CM, Lundwall A, Wydro R. et al. Molecular analysis of the gene for vitamin K dependent protein S and its pseudogene. Cloning and partial gene organization. Biochemistry 1990; 29: 7861-7868.
  • 11 Ploos van Amstel HK, Reitsma PH, van der Logt CP. et al. Intron-exon organization of the active human protein S gene PS alpha and its pseudogene PS beta: duplication and silencing during primate evolution. Biochemistry 1990; 29: 7853-7861.
  • 12 Schmidel DK, Tatro AV, Phelps LG. et al. Organization of the human protein S genes. Biochemistry 1990; 29: 7845-7852.
  • 13 Gandrille S, Borgel D, Sala N. et al. Protein S deficiency: a database of mutations--summary of the first update. Thromb Haemost 2000; 84: 918.
  • 14 Lanke E, Johansson AM, Hillarp A. et al. Co-segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1. J Thromb Haemost 2004; 2: 1918-1923.
  • 15 Ploos van Amstel HK, Huisman MV, Reitsma PH. et al. Partial protein S gene deletion in a family with hereditary thrombophilia. Blood 1989; 73: 479-483.
  • 16 Schmidel DK, Nelson RM, Broxson Jr. EH. et al. A 5.3-kb deletion including exon XIII of the protein S a gene occurs in two protein S-deficient families. Blood 1991; 77: 551-559.
  • 17 Holmes ZR, Bertina RM, Reitsma PH. Characterization of a large chromosomal deletion in the PROS1 gene of a patient with protein S deficiency type I using long PCR. Br J Haematol 1996; 92: 986-991.
  • 18 Johansson AM, Hillarp A, Sall T. et al. Large deletions of the PROS1 gene in a large fraction of mutation-negative patients with protein S deficiency. Thromb Haemost 2005; 94: 951-957.
  • 19 Schouten JP, McElgunn CJ, Waaijer R. et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30: e57.
  • 20 Sellner LN, Taylor GR. MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat 2004; 23: 413-419.
  • 21 Koolen DA, Vissers LE, Pfundt R. et al. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet 2006; 38: 999-1001.
  • 22 Lai KK, Lo IF, Tong TM. et al. Detecting exon deletions and duplications of the DMD gene using Multiplex Ligation-dependent Probe Amplification (MLPA). Clin Biochem 2006; 39: 367-372.
  • 23 Rooms L, Reyniers E, Wuyts W. et al. Multiplex ligation- dependent probe amplification to detect subtelomeric rearrangements in routine diagnostics. Clin Genet 2006; 69: 58-64.
  • 24 Sakata T, Okamoto A, Mannami T. et al. Protein C and antithrombin deficiency are important risk factors for deep vein thrombosis in Japanese. J Thromb Haemost 2004; 2: 528-530.
  • 25 Hoebeeck J, van der Luijt R, Poppe B. et al. Rapid detection of VHL exon deletions using real-time quantitative PCR. Lab Invest 2005; 85: 24-33.
  • 26 Vandesompele J, De Preter K, Pattyn F. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: Research0034.
  • 27 Okuda T, Fujioka Y, Kamide K. et al. Verification of 525 coding SNPs in 179 hypertension candidate genes in the Japanese population: identification of 159 SNPs in 93 genes. J Hum Genet 2002; 47: 387-394.
  • 28 Kimura R, Kokubo Y, Miyashita K. et al. Polymorphisms in vitamin K-dependent γ-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population. Int J Hematol 2006; 84: 387-397.
  • 29 Tanaka C, Kamide K, Takiuchi S. et al. An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms. Hypertens Res 2003; 26: 301-306.
  • 30 Lakich D, Kazazian Jr. HH, Antonarakis SE. et al. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet 1993; 5: 236-241.
  • 31 Tatewaki H, Tsuda H, Kanaji T. et al. Characterization of the human protein S gene promoter: a possible role of transcription factors Sp1 and HNF3 in liver. Thromb Haemost 2003; 90: 1029-1039.
  • 32 Stankiewicz P, Lupski JR. Genome architecture, rearrangements and genomic disorders. Trends Genet 2002; 18: 74-82.
  • 33 Redon R, Ishikawa S, Fitch KR. et al. Global variation in copy number in the human genome. Nature 2006; 444: 444-454.
  • 34 Bailey JA, Gu Z, Clark RA. et al. Recent segmental duplications in the human genome. Science 2002; 297: 1003-1007.
  • 35 Shaw CJ, Lupski JR. Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum Mol Genet 2004; 13: R57-64.